Dr. Valeria Visconte is a Project Staff scientist in the Department of Translational Hematology & Oncology Research at Cleveland Clinic’s Taussig Cancer Institute and an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Her research focuses on the genetic mechanisms underlying bone marrow failure disorders, particularly myelodysplastic syndromes (MDS), with the goal of developing more precise therapeutic strategies for patients with myeloid malignancies.
Dr. Visconte’s work integrates cancer genetics, genomics, transcriptomics, and experimental therapeutics to investigate the functional consequences of mutations associated with myeloid diseases. Her laboratory also studies RNA splicing, molecular biomarkers, machine learning applications in genomics, and novel targeted therapies for hematologic malignancies.
She earned her bachelor’s degree in Biology and her PhD in Molecular Genetics from the University of Naples Federico II. She completed fellowship training at the National Heart, Lung, and Blood Institute (NIH) and at Cleveland Clinic before joining the faculty. Dr. Visconte has authored more than 100 peer-reviewed publications and has received numerous awards supporting her research in myelodysplastic syndromes and bone marrow failure disorders.
Research Information
Research Interests
- Myelodysplastic syndromes (MDS)
- Bone marrow failure disorders
- Myeloid malignancies
- Cancer genomics
- RNA splicing biology
- Experimental therapeutics
- Machine learning applications in genomics
- Precision medicine
- VEXAS syndrome
- Molecular biomarkers
Awards and Honors
Professional Memberships
External Appointments
- Problem-Based Learning Educator, Cleveland Clinic Lerner College of Medicine (2022–present)
- Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University (2017–present)